BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Emmaus Medical, Inc. 

3870 Del Amo Boulevard
Unit 507
Torrance  California  90503-7701  U.S.A.
Phone: 310-214-0065 Fax: 310-214-0075


SEARCH JOBS




Industry
Biotechnology






 Company News
Emmaus Medical, Inc. Announces Completion Of All Patient Visits For Its Phase 3 Clinical Trial For Treatment Of Sickle Cell Disease 1/7/2014 11:10:13 AM
Former FDA Official Tim Cote JoinsEmmaus Medical, Inc. as Regulatory Advisor 5/9/2013 7:03:13 AM
Emmaus Medical, Inc. to Present at 6th Annual OneMedForum 12/20/2012 6:18:59 AM
Emmaus Medical, Inc. Announces Completion of Enrollment for Its Phase 3 Sickle Cell Disease Trial 12/3/2012 9:19:11 AM
Emmaus Medical, Inc. CEO Yutaka Niihara, M.D., Issues Statement in Connection With Status of Company's Phase III FDA Sickle Cell Treatment Trials 11/19/2012 10:35:12 AM
Emmaus Medical, Inc. Marks Progression of Phase 3 Sickle Cell Disease Clinical Trial During Sickle Cell Awareness Month 9/13/2012 9:49:19 AM
European Commission Grants Orphan Medicinal Product Designation for Emmaus Medical, Inc.'s Sickle Cell Treatment 7/17/2012 9:26:49 AM
Emmaus Medical, Inc.'s Sickle Cell Treatment Receives Positive Opinion for Orphan Drug Status from European Medicines Agency 5/29/2012 11:11:10 AM
Dr. Henry A. McKinnell Jr. Joins Emmaus Medical, Inc. Board of Directors 5/18/2010 9:31:07 AM
Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome 12/20/2007 8:20:38 AM